ConductScience.org, home

Paper35348191

Ricolinostat enhances adavosertib‑induced mitotic catastrophe in TP53‑mutated head and neck squamous cell carcinoma cells.

Miyake K and 6 others. Int J Oncol, 2022. Cited by 21 papers, by iCite.

Cite this record

ConductScience Library. Ricolinostat enhances adavosertib‑induced mitotic catastrophe in TP53‑mutated head and neck squamous cell carcinoma cells. Papers, record 35348191. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35348191

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Ricolinostat enhances adavosertib‑induced mitotic catastrophe in TP53‑mutated head and neck squamous cell carcinoma cells.
PubMed
Journal
Int J Oncol
PubMed
Year
2022
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
21
iCite
Relative citation ratio, by iCite
1.71
iCite
Revised in PubMed
2022-04-13
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Miyake KKeitaro
2Takano NNaoharu
3Kazama HHiromi
4Kikuchi HHiroyuki
5Hiramoto MMasaki
6Tsukahara KKiyoaki
7Miyazawa KKeisuke

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Head and Neck NeoplasmsMajor topic
Tumor Suppressor Protein p53Major topic
Apoptosis
Cell Line, Tumor
Humans
Hydroxamic Acids
Pyrazoles
Pyrimidines
Pyrimidinones
Squamous Cell Carcinoma of Head and Neck

Source PubMed

Download CSV of topics

References56

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118201278Histone deacetylase inhibitors enhance the chemosensitivity of tumor cells with cross-resistance to a wide range of DNA-damaging drugs.Cancer Sci2008https://conductscience.org/library/papers/18201278PubMed
223520471Wee1 inhibition by MK-1775 leads to tumor inhibition and enhances efficacy of gemcitabine in human sarcomas.PLoS One2013https://conductscience.org/library/papers/23520471PubMed
321798893The mutational landscape of head and neck squamous cell carcinoma.Science2011https://conductscience.org/library/papers/21798893PubMed
415077146Cell death by mitotic catastrophe: a molecular definition.Oncogene2004https://conductscience.org/library/papers/15077146PubMed
52175676The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53.Cell1990https://conductscience.org/library/papers/2175676PubMed
629954437Augmented antitumor activity by olaparib plus AZD1775 in gastric cancer through disrupting DNA damage repair pathways and DNA damage checkpoint.J Exp Clin Cancer Res2018https://conductscience.org/library/papers/29954437PubMed
719402126The histone deacetylase inhibitor LBH589 inhibits expression of mitotic genes causing G2/M arrest and cell death in head and neck squamous cell carcinoma cell lines.J Pathol2009https://conductscience.org/library/papers/19402126PubMed
827880943TP53 mutations, expression and interaction networks in human cancers.Oncotarget2017https://conductscience.org/library/papers/27880943PubMed
97626804The Wee1 protein kinase regulates T14 phosphorylation of fission yeast Cdc2.Mol Biol Cell1995https://conductscience.org/library/papers/7626804PubMed
1022553330Activation of cap-dependent translation by mucosal human papillomavirus E6 proteins is dependent on the integrity of the LXXLL binding motif.J Virol2012https://conductscience.org/library/papers/22553330PubMed
1122957056Depletion of HDAC6 enhances cisplatin-induced DNA damage and apoptosis in non-small cell lung cancer cells.PLoS One2012https://conductscience.org/library/papers/22957056PubMed
1232958072A WEE1 family business: regulation of mitosis, cancer progression, and therapeutic target.J Hematol Oncol2020https://conductscience.org/library/papers/32958072PubMed
1332611648A Biomarker-enriched, Randomized Phase II Trial of Adavosertib (AZD1775) Plus Paclitaxel and Carboplatin for Women with Platinum-sensitive TP53-mutant Ovarian Cancer.Clin Cancer Res2020https://conductscience.org/library/papers/32611648PubMed
1419010849Ubiquitin proteasome system stress underlies synergistic killing of ovarian cancer cells by bortezomib and a novel HDAC6 inhibitor.Clin Cancer Res2008https://conductscience.org/library/papers/19010849PubMed
1521037108Selective inhibition of histone deacetylase 6 (HDAC6) induces DNA damage and sensitizes transformed cells to anticancer agents.Proc Natl Acad Sci U S A2010https://conductscience.org/library/papers/21037108PubMed
1630662800Antitumor activity of the novel HDAC inhibitor CUDC-101 combined with gemcitabine in pancreatic cancer.Am J Cancer Res2018https://conductscience.org/library/papers/30662800PubMed
1715916966HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor.Mol Cell2005https://conductscience.org/library/papers/15916966PubMed
1824013427Wee1 kinase as a target for cancer therapy.Cell Cycle2013https://conductscience.org/library/papers/24013427PubMed
1934286042An Image-based Assay for High-throughput Analysis of Cell Proliferation and Cell Death of Adherent Cells.Bio Protoc2018https://conductscience.org/library/papers/34286042PubMed
2022766642Overexpression of histone deacetylase 6 contributes to accelerated migration and invasion activity of hepatocellular carcinoma cells.Oncol Rep2012https://conductscience.org/library/papers/22766642PubMed

See all 56 referencesDownload CSV of references

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.

PMIDTitleJournalYearIn PapersSource
42939551Advances in p53 Therapies for Oral Squamous Cell Carcinoma: A Literature Review.Curr Issues Mol Biol2026https://conductscience.org/library/papers/42939551PubMed
42469385A Rho GTPase-related gene signature predicts prognosis and reveals an immunosuppressive microenvironment in lung adenocarcinoma: an integrated analysis of bulk and single-cell RNA sequencing data.Sci Rep2026https://conductscience.org/library/papers/42469385PubMed
41940897Unraveling the molecular landscape: an overview on gene expression, epigenetic alterations, and therapeutic challenges in head and neck squamous cell carcinoma.Mol Genet Genomics2026https://conductscience.org/library/papers/41940897PubMed
40468445WNT3 promotes chemoresistance to oxaliplatin in oral squamous cell carcinoma via regulating ABCG2 expression.Cell Biosci2025https://conductscience.org/library/papers/40468445PubMed
39800760Combinatorial functionomics identifies HDAC6-dependent molecular vulnerability of radioresistant head and neck cancer.Exp Hematol Oncol2025https://conductscience.org/library/papers/39800760PubMed
39301607Advanced Human Papillomavirus-Negative Head and Neck Squamous Cell Carcinoma: Unmet Need and Emerging Therapies.Mol Cancer Ther2024https://conductscience.org/library/papers/39301607PubMed
39199381The Function of H2A Histone Variants and Their Roles in Diseases.Biomolecules2024https://conductscience.org/library/papers/39199381PubMed
39063958Selective HDAC6 Inhibition Has the Potential for Anti-Cancer Effect in Renal Cell Carcinoma.J Pers Med2024https://conductscience.org/library/papers/39063958PubMed
38702756Targeting histone deacetylases in head and neck squamous cell carcinoma: molecular mechanisms and therapeutic targets.J Transl Med2024https://conductscience.org/library/papers/38702756PubMed
38684944HIST3H2A promotes the progression of prostate cancer through inhibiting cell necroptosis.BMC Cancer2024https://conductscience.org/library/papers/38684944PubMed
38539518TP53 and/or BRCA1 Mutations Based on CtDNA Analysis as Prognostic Biomarkers for Primary Triple-Negative Breast Cancer.Cancers (Basel)2024https://conductscience.org/library/papers/38539518PubMed
37834095Bortezomib Is Effective in the Treatment of T Lymphoblastic Leukaemia by Inducing DNA Damage, WEE1 Downregulation, and Mitotic Catastrophe.Int J Mol Sci2023https://conductscience.org/library/papers/37834095PubMed
36338767Targeting DNA damage response as a potential therapeutic strategy for head and neck squamous cell carcinoma.Front Oncol2022https://conductscience.org/library/papers/36338767PubMed
36076996Targeting HDAC6 to Overcome Autophagy-Promoted Anti-Cancer Drug Resistance.Int J Mol Sci2022https://conductscience.org/library/papers/36076996PubMed
36036883HDAC6: A unique HDAC family member as a cancer target.Cell Oncol (Dordr)2022https://conductscience.org/library/papers/36036883PubMed
36012642Evaluation of the Therapeutic Potential of Histone Deacetylase 6 Inhibitors for Primary and Metastatic Uveal Melanoma.Int J Mol Sci2022https://conductscience.org/library/papers/36012642PubMed
35652048Role of Selective Histone Deacetylase 6 Inhibitor ACY-1215 in Cancer and Other Human Diseases.Front Pharmacol2022https://conductscience.org/library/papers/35652048PubMed

Download CSV of cited by

Genes18

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ATM472PubTator's text mininghttps://conductscience.org/library/genes/472NCBI Gene
ATR545PubTator's text mininghttps://conductscience.org/library/genes/545NCBI Gene
CASP3836PubTator's text mininghttps://conductscience.org/library/genes/836NCBI Gene
CDC25C995PubTator's text mininghttps://conductscience.org/library/genes/995NCBI Gene
CDK1983PubTator's text mininghttps://conductscience.org/library/genes/983NCBI Gene
CHEK11111PubTator's text mininghttps://conductscience.org/library/genes/1111NCBI Gene
CHEK211200PubTator's text mininghttps://conductscience.org/library/genes/11200NCBI Gene
CHKA1119PubTator's text mininghttps://conductscience.org/library/genes/1119NCBI Gene
H2AX3014PubTator's text mininghttps://conductscience.org/library/genes/3014NCBI Gene
H2BC218349PubTator's text mininghttps://conductscience.org/library/genes/8349NCBI Gene
HDAC610013PubTator's text mininghttps://conductscience.org/library/genes/10013NCBI Gene
HDAC99734PubTator's text mininghttps://conductscience.org/library/genes/9734NCBI Gene
PARP1142PubTator's text mininghttps://conductscience.org/library/genes/142NCBI Gene
POTEF728378PubTator's text mininghttps://conductscience.org/library/genes/728378NCBI Gene
TP537157PubTator's text mininghttps://conductscience.org/library/genes/7157NCBI Gene
TUBA1A7846PubTator's text mininghttps://conductscience.org/library/genes/7846NCBI Gene
TUBA1B10376PubTator's text mininghttps://conductscience.org/library/genes/10376NCBI Gene
WEE17465PubTator's text mininghttps://conductscience.org/library/genes/7465NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35348191

GET https://conductscience.org/api/papers/v1/35348191/references?page=2